🔗 Share this article

This year's prestigious award in medical science was granted for revolutionary findings that illuminate how the body's defense network attacks harmful pathogens while protecting the healthy tissues.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—share this accolade.

Their work identified unique "sentinels" within the immune system that remove malfunctioning defense cells that could attacking the body.

The findings are now enabling innovative therapies for immune disorders and malignancies.

The winners will share a monetary award valued at 11 million SEK.

Crucial Discoveries

"The research has been essential for comprehending how the body's defenses functions and the reason we don't all suffer from severe autoimmune diseases," stated the head of the award panel.

The team's studies address a fundamental mystery: How does the immune system defend us from numerous infections while keeping our own tissues unharmed?

Our immune system employs immune cells that scan for indicators of disease, including pathogens and germs it has not met before.

These cells employ detectors—called recognition units—that are produced randomly in countless combinations.

This provides the immune system the ability to combat a wide array of invaders, but the randomness of the mechanism unavoidably produces immune cells that may attack the host.

Security Guards of the Body

Researchers earlier knew that some of these harmful defense cells were eliminated in the thymus—the site where immune cells develop.

The latest Nobel Prize honors the discovery of T-reg cells—described as the body's "peacekeepers"—which travel through the system to disarm other immune cells that attack the body's own tissues.

It is known that this mechanism fails in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

The prize committee added, "The discoveries have laid the foundation for a new field of investigation and accelerated the development of new treatments, for instance for cancer and immune disorders."

In cancer, regulatory T-cells block the body from attacking the tumor, so research are aimed at reducing their numbers.

In autoimmune diseases, experiments are exploring increasing regulatory T-cells so the body is no longer under attack. A similar approach could also be effective in reducing the chances of transplanted organ failure.

Innovative Studies

Prof Sakaguchi, from a Japanese institution, conducted tests on mice that had their thymus removed, leading to autoimmune disease.

The researcher demonstrated that injecting immune cells from healthy mice could prevent the illness—suggesting there was a system for blocking immune cells from attacking the host.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an inherited autoimmune disease in rodents and humans that resulted in the identification of a genetic factor critical for how regulatory T-cells operate.

"Their groundbreaking research has revealed how the body's defenses is kept in check by regulatory T cells, preventing it from mistakenly targeting the healthy cells," commented a prominent physiology expert.

"This work is a remarkable example of how fundamental physiological study can have far-reaching consequences for human health."